Polycystic Ovary Syndrome clinical trials

Explore recruiting polycystic ovary syndrome clinical trials.

Recruiting polycystic ovary syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Polycystic Ovary Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Acupuncture or Metformin for Insulin Resistance in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS).

Austria, Spain, Denmark, Norway, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Optimizing metformin use in polycystic ovary syndrome - A randomized controlled trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Insemination in patients with polycystic ovary syndrome: gestation rates using two stimulation patterns: letrozole vs gonadotropins.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS)

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Polycystic Ovary Syndrome trials by city

Polycystic Ovary Syndrome in Toronto Polycystic Ovary Syndrome in Vancouver Polycystic Ovary Syndrome in Montreal Polycystic Ovary Syndrome in Calgary Polycystic Ovary Syndrome in Edmonton Polycystic Ovary Syndrome in Ottawa Polycystic Ovary Syndrome in Winnipeg Polycystic Ovary Syndrome in Quebec City Polycystic Ovary Syndrome in Hamilton Polycystic Ovary Syndrome in Kitchener Polycystic Ovary Syndrome in London Polycystic Ovary Syndrome in Halifax Polycystic Ovary Syndrome in New York Polycystic Ovary Syndrome in Los Angeles Polycystic Ovary Syndrome in Chicago Polycystic Ovary Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease